Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study

INTRODUCTION: Endothelial dysfunction is a risk factor for cardiovascular disease in patients with diabetes. We hypothesized that imeglimin, a novel oral hypoglycemic agent, would improve endothelial function. METHODS: In this study, imeglimin was administered to patients with type 2 diabetes and Hb...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Taisuke, Ueno, Hiroaki, Konagata, Ayaka, Taniguchi, Norifumi, Kogo, Fumiko, Nagatomo, Yuma, Shimizu, Koichiro, Yamaguchi, Hideki, Shimoda, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981829/
https://www.ncbi.nlm.nih.gov/pubmed/36732433
http://dx.doi.org/10.1007/s13300-023-01370-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981829/
https://www.ncbi.nlm.nih.gov/pubmed/36732433
http://dx.doi.org/10.1007/s13300-023-01370-z

Ejemplares similares